Greater China
China's Zhihu completes $522m IPO, endures volatile debut
Chinese question-and-answer platform Zhihu endured a difficult New York Stock Exchange debut, closing at a 10.5% discount to its IPO price on a day when US-listed Chinese stocks fluctuated wildly.
PE topples advisory as China Renaissance's key business
Fund management has become China Renaissance’s largest source of revenue, seven years after the firm – best known for providing private placement and M&A advisory services to Chinese internet companies – entered the private equity business.
Baring targets $8.5b for eighth pan-Asia fund
Baring Private Equity Asia is back in the market seeking $8.5 billion for its eighth pan-regional fund, less than 15 months after closing Fund VII at $6.5 billion.
China yogurt brand secures $122m Series B
Simple Love, also known as Jian’Ai, a Chinese yogurt brand, has raised RMB800 million ($122 million) in Series B funding from Matrix Partners China, BA Capital, CITIC Agriculture Fund, and Maison Capital. They all backed the company's RMB400 million Series...
China autonomous driving start-up TuSimple files for US IPO
TuSimple, a China and US-based developer of autonomous driving technology for trucks, has filed for a US IPO. Its backers include CDH Investments, Zhiping Capital, Sina Corporation, and Hong Kong hedge fund Composite Capital.
Hony launches China healthcare, consumer SPAC
Hony Capital has joined a string of Chinese private equity managers with special purpose acquisition vehicles (SPACs), targeting $300 million for healthcare and consumer deals.
JC Flowers exits Asia trading platforms business
JC Flowers has agreed to sell Hong Kong-based Chi-X Asia Pacific, which operates equity trading platforms in Australia and Japan, to US-based Cboe Global Markets.
Invesco leads $155m round for China's Brii Biosciences
Invesco has led a $155 million Series C round for China-focused infectious diseases drug developer Brii Biosciences.
CMB, Mirae lead Series C for China biotech player EpimAb
Shanghai-based EpimAb Biotherapeutics has raised $120 million in Series C funding led by CMB International and Korea’s Mirae Asset Financial Group.
China drug development outsourcer raises $70m
Zhenge Biotech – a Shanghai-based contract development and manufacturing organization (CDMO) for large molecule drugs – has raised $70 million in Series B funding led by Qiming Venture Partners and IDG Capital.
China's Taishan Beer raises $92m
CMC Capital Group has committed RMB600 million ($92 million) in funding to Chinese domestic beer brand Taishan.
China direct lending: Creative credit
A combination of improved collateral, rising yields and robust demand is drawing investors to China’s direct lending space. Opportunities abound, but local execution remains critical
Bain backs China gas station platform Newlink
Bain Capital Private Equity led a $200 million investment in Newlink Group, operator of a platform that helps drivers in China locate the best value gas stations and charging piles. Joy Capital re-upped in the round.
Brookfield hires ex-Blackstone executive to lead China PE
Alex Yang, formerly a senior managing director at The Blackstone Group, has been recruited by Brookfield Asset Management to lead its private equity business in China.
China's Connect Biopharma gains 8% on debut after $191m US IPO
Connect Biopharma, a China-headquartered drug developer specializing in treatments for T cell-driven inflammatory diseases, gained 8.8% on debut following a $191.3 million US IPO.
China autonomous driving developer Momenta raises $500m
SAIC Motor, Toyota Motor Corporation, Robert Bosch, Yunfeng Capital, and Temasek Holdings are among the investors in a $500 million Series C funding round for Chinese autonomous driving technology developer Momenta.
China cybersecurity player ThreatBook raises $77m
Beijing-based cybersecurity solutions provider ThreatBook has completed a RMB500 million ($77 million) Series E round led by CPE and featuring existing investor V Fund.
China's Tuya completes $915m IPO, gains on debut
Tuya, a Chinese start-up that claims to be the world’s largest platform-as-a-service (PaaS) provider in terms of number of smart devices powered, raised $915.4 million in its US IPO. The offering was priced above the indicative range yet still registered...
China's GSR Ventures appoints first female managing director
Yutong Zhang has become the first woman to join the team of managing directors that leads Chinse VC firm GSR Ventures.
Hong Kong's Gly Capital launches $300m mobility tech fund
Gly Capital, a Hong Kong-based investor controlled by Chinese auto giant Geely, has launched a $300 million mobility tech fund.
Temasek leads round for China marketing content start-up
Tezign, a Chinese start-up that serves as a content-focused one-stop marketing solutions platform, has closed a second tranche of Series C funding that takes the overall total for the round to $100 million.
China biotech makes Asia global healthcare PE leader
A more than 100% year-on-year increase in deal volume saw Asia Pacific overtake North America to become the most active global private equity healthcare market for the first time in 2020.
China's B2B trading platform Ichunt raises $100m
Ichunt.com, a Chinese B2B trading platform for electronic components, has raised nearly $100 million in Series C funding from JD MRO, the industrial supplies business of local e-commerce giant JD.com.
CMB, Tiantu lead $300m Series D for China's Guoquan
Guoquan, a Chinese hot pot ingredients supplier, has raised a $300 million Series D round led by CMB International and Tiantu Capital.